ZA704981B - A process for the resolution of dl-5-(3-tert-butylamino-2-hydroxypropoxy)3,4-dihydro-1(2h)naphthalenone - Google Patents

A process for the resolution of dl-5-(3-tert-butylamino-2-hydroxypropoxy)3,4-dihydro-1(2h)naphthalenone

Info

Publication number
ZA704981B
ZA704981B ZA704981A ZA704981A ZA704981B ZA 704981 B ZA704981 B ZA 704981B ZA 704981 A ZA704981 A ZA 704981A ZA 704981 A ZA704981 A ZA 704981A ZA 704981 B ZA704981 B ZA 704981B
Authority
ZA
South Africa
Prior art keywords
naphthalenone
hydroxypropoxy
butylamino
dihydro
tert
Prior art date
Application number
ZA704981A
Other languages
English (en)
Inventor
J Shavel
C Schwender
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA704981B publication Critical patent/ZA704981B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA704981A 1969-09-17 1970-07-20 A process for the resolution of dl-5-(3-tert-butylamino-2-hydroxypropoxy)3,4-dihydro-1(2h)naphthalenone ZA704981B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (1)

Publication Number Publication Date
ZA704981B true ZA704981B (en) 1971-07-28

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA704981A ZA704981B (en) 1969-09-17 1970-07-20 A process for the resolution of dl-5-(3-tert-butylamino-2-hydroxypropoxy)3,4-dihydro-1(2h)naphthalenone

Country Status (13)

Country Link
US (1) US3649691A (es)
JP (1) JPS494218B1 (es)
BE (1) BE755071A (es)
BR (1) BR7022215D0 (es)
CH (1) CH540882A (es)
DE (1) DE2046043C3 (es)
DK (1) DK139356B (es)
ES (1) ES383643A1 (es)
FR (1) FR2068537B1 (es)
GB (1) GB1264775A (es)
NL (1) NL7013663A (es)
NO (1) NO135141C (es)
ZA (1) ZA704981B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (es) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (es) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
DK139356B (da) 1979-02-05
DE2046043A1 (de) 1971-03-25
JPS494218B1 (es) 1974-01-31
GB1264775A (es) 1972-02-23
CH540882A (de) 1973-08-31
US3649691A (en) 1972-03-14
NO135141C (es) 1977-02-16
BE755071A (fr) 1971-02-22
DE2046043B2 (de) 1978-03-30
NO135141B (es) 1976-11-08
NL7013663A (es) 1971-03-19
BR7022215D0 (pt) 1973-04-26
ES383643A1 (es) 1976-06-01
DK139356C (es) 1979-08-20
DE2046043C3 (de) 1978-12-14
FR2068537A1 (es) 1971-08-27
FR2068537B1 (es) 1974-02-01

Similar Documents

Publication Publication Date Title
YU33176A (en) Process for preparing new substituted n-allyl-2-arylamino- imidazolines-(2)
ZA704981B (en) A process for the resolution of dl-5-(3-tert-butylamino-2-hydroxypropoxy)3,4-dihydro-1(2h)naphthalenone
YU324080A (en) Process for obtaining 14 beta-alkyloxamorphinane
ZA703657B (en) Process for the production of new derivatives of the dibenzo(a,e)cycloocten-5,11-imine
YU47970A (en) Process for preparing 4,20,22- bufatrienolide-rhamnoside-ethers
YU39722B (en) Process for obtaining 0,0-diethyldithio-phoshoryl-methyl-3-chloro-6-benzoxazolone
YU36021B (en) Process for preparing new 1.2.3-trithiocyclohexane compounds
ZA711302B (en) Process for the manufacture of a pigment
YU34354B (en) Process for preparing 4-aryl-1-(4,4-diaryl-butyl)-4hydroxypiperidines
IL36516A0 (en) Process for the manufacture of 2,2-disubstituted cycloalkene-1,3-diones
YU112271A (en) Process for obtaining the new 1-veratry-4-methyl-5-ethyl-7,8-dimethoxy-2,3-diazobicyclo(5,4,0)undecepataene-(1,3,6,8,10)
CA968797A (en) Process for making pyrazolo-(3,4-d)-pyrimides
YU35257B (en) Process for obtaining 1,2,3,4,10,10 a-hexahydropyrazino(1,2:a)indole-2-carboxamidine
ZA713768B (en) Process for the manufacture of 1,1,2,2-tetrahydroperfluoro-alkanols
YU206774A (en) Process for obtaining 3,4-diamino-benzophenones
AU437390B2 (en) A process for the resolution of dl-5-3 tertbutylamino 2-hydroxypropoxy -3, 4 - dihydro-1 naphthalenone
ZA704089B (en) Bicyclo 2.2.2-octane-1-acetic acid derivatives
AU1829370A (en) A process for the resolution of dl-5-3 tertbutylamino 2-hydroxypropoxy -3, 4 - dihydro-1 naphthalenone
IL35278A0 (en) Process for the preparation of 4,5,6,7-tetrahydrocyclopenta-1,3-dioxinones-(4)
YU37142B (en) Process for obtaining 1,2-diphenyl-3,5-dioxo-4-substituted pyrazlidines
YU35330B (en) Process for preparing bicyclo-(3,3,0)-octene-(2) from cyclooctadiene-(1,5)
YU35265B (en) Process for obtaining 0,0-diethyl-phthalimidophosphonothioate
MY7000055A (en) A process for the manufacture of benidiaz (1,4) epines
YU34536B (en) Process for preparing 7 delta-methyl-1 delta, 2 delta-methylene-androstenolones
CA823694A (en) Process for the production of 7-methylene-bicyclo (3.3.1) nonan-3-one